Anti-Cancer Drugs Issues Research Articles in November 2024 Edition
October 23, 2024
October 23, 2024
LONDON, England, Oct. 23 -- Anti-Cancer Drugs, a peer-reviewed journal that says it reports clinical and experimental results related to anti-cancer drugs and welcomes contributions on anti-cancer drug design, drug delivery, pharmacology, hormonal and biological modalities and chemotherapy evaluation, published research articles on the following topics in its November 2024 edition (Vol. 35, Issue 10):
Pre-Clinical Reports
* Differential functionality of fluoropyrimidine . . .
Pre-Clinical Reports
* Differential functionality of fluoropyrimidine . . .